Clin2
NCT07489430Possibly a fitNot yet recruiting

DaxibotulinumtoxinA for eyelid spasms

Blepharospasm of Both EyelidsBlepharospasm of Left EyelidBlepharospasm of Right EyelidBlepharospasm, Benign EssentialBlepharospasm

Treatments studied

Part of Brain & nervous system, Eyes & vision clinical trials.

This trial tests a new botulinum toxin injection for people with disruptive eyelid spasms (blepharospasm). It may offer longer-lasting relief with potentially fewer side effects for those who currently use other botulinum toxin injections.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
20 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • 18 years or older
  • Have disruptive eyelid spasms that need ongoing botulinum toxin shots
  • Currently getting onabotulinumtoxinA (Botox) or incobotulinumtoxinA (Xeomin) for your eyelid spasms, but the effect lasts less than 12 weeks and your doctor says no higher dose is safe
  • No other major eye problems or conditions like myasthenia gravis or ALS
  • Not pregnant, breastfeeding, or planning pregnancy in the next 15 months

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06195241Recruiting· Phase 4
DaxibotulinumtoxinA for eyelid and facial spasms

This trial tests a new type of botulinum toxin (DaxibotulinumtoxinA) for people with eyelid or facial muscle spasms. It aims to see if it works better or lasts longer than current treatments.

The Bronx, New York
NCT00001208Recruiting
Botulinum toxin for involuntary movement and muscle disorders

This study tests botulinum toxin (a medication that relaxes muscles) to treat various involuntary movements like tremors, muscle spasms, or uncontrolled facial movements. The goal is to see if this treatment can reduce your symptoms and improve your quality of life.

Bethesda, Maryland
NCT03977493Recruiting· Phase 3
Xeomin injections for focal hand muscle spasms

This trial tests incobotulinumtoxinA (Xeomin) injections to reduce focal hand dystonia—unwanted muscle tightening in the hand. You may be able to join whether you’ve had this condition before or have tried similar injections in the past, as long as certain safety rules are met.

Bern
NCT07180394Not yet recruiting
Botulinum toxin for eye misalignment

This trial tests whether a safe, purified protein (botulinum toxin) can help straighten eyes that are misaligned (esotropia or exotropia). It is for people with small-to-moderate eye turns, including those from nerve issues, thyroid disease, or after surgery.

Rawalpindi, Punjab Province
NCT06771323Recruiting· Phase 2
Adding valbenazine to botox for neck muscle spasms

This study tests if adding a daily pill (valbenazine) to regular botox injections can better reduce neck muscle spasms. It helps people whose botox works but may not be enough.

Richmond, Virginia
NCT06937931Recruiting· Phase 2
Study of IPN10200 for neck muscle spasms in adults

This trial tests a new botulinum toxin medication (IPN10200) for adults with cervical dystonia, a condition that causes painful muscle spasms in the neck and shoulders. It aims to see if the treatment is safe and effective in reducing symptoms.

Tucson, Arizona

Hear when a new Blepharospasm of Both Eyelids trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.